Click here to get full coverage on Xencor (XNCR) Heads To Cantor Conference With Fair Value Still In Focus - simplywall.st

Xencor (XNCR) Heads To Cantor Conference With Fair Value Still In Focus  simplywall.st

Xencor (XNCR) Heads To Cantor Conference With Fair Value Still In Focus - simplywall.st

Click here to get full coverage on Avoiding Lag: Real-Time Signals in (XNCR) Movement - news.stocktradersdaily.com

Avoiding Lag: Real-Time Signals in (XNCR) Movement  news.stocktradersdaily.com

Avoiding Lag: Real-Time Signals in (XNCR) Movement - news.stocktradersdaily.com

Click here to get full coverage on $XNCR stock is down 11% today. Here's what we see in our data. - Quiver Quantitative

$XNCR stock is down 11% today. Here's what we see in our data.  Quiver Quantitative

$XNCR stock is down 11% today. Here's what we see in our data. - Quiver Quantitative

Click here to get full coverage on Barclays Maintains Xencor(XNCR.US) With Buy Rating, Raises Target Price to $35 - Moomoo

Barclays Maintains Xencor(XNCR.US) With Buy Rating, Raises Target Price to $35  Moomoo

Barclays Maintains Xencor(XNCR.US) With Buy Rating, Raises Target Price to $35 - Moomoo

Click here to get full coverage on Xencor (XNCR) Soars 16.9%: Is Further Upside Left in the Stock? - Yahoo Finance

Xencor (XNCR) Soars 16.9%: Is Further Upside Left in the Stock?  Yahoo Finance

Xencor (XNCR) Soars 16.9%: Is Further Upside Left in the Stock? - Yahoo Finance

Click here to get full coverage on Hsbc Holdings PLC Has $2.08 Million Position in Xencor, Inc. $XNCR - MarketBeat

Hsbc Holdings PLC Has $2.08 Million Position in Xencor, Inc. $XNCR  MarketBeat

Hsbc Holdings PLC Has $2.08 Million Position in Xencor, Inc. $XNCR - MarketBeat

Click here to get full coverage on XNCR: Late-stage T-cell engager and immunology programs advance, with pivotal data expected soon - TradingView

XNCR: Late-stage T-cell engager and immunology programs advance, with pivotal data expected soon  TradingView

XNCR: Late-stage T-cell engager and immunology programs advance, with pivotal data expected soon - TradingView

Click here to get full coverage on XNCR - Xencor Inc Stock Price and Quote - Finviz

XNCR - Xencor Inc Stock Price and Quote  Finviz

XNCR - Xencor Inc Stock Price and Quote - Finviz

Click here to get full coverage on How Investors May Respond To Xencor (XNCR) Narrowing Quarterly Losses Amid Deeper First‑Half Deficit - Yahoo Finance

How Investors May Respond To Xencor (XNCR) Narrowing Quarterly Losses Amid Deeper First‑Half Deficit  Yahoo Finance

How Investors May Respond To Xencor (XNCR) Narrowing Quarterly Losses Amid Deeper First‑Half Deficit - Yahoo Finance

Click here to get full coverage on Man Group plc Takes Position in Xencor, Inc. $XNCR - MarketBeat

Man Group plc Takes Position in Xencor, Inc. $XNCR  MarketBeat

Man Group plc Takes Position in Xencor, Inc. $XNCR - MarketBeat

Click here to get full coverage on XNCR Forecast — Price Target — Prediction for 2027 - TradingView

XNCR Forecast — Price Target — Prediction for 2027  TradingView

XNCR Forecast — Price Target — Prediction for 2027 - TradingView

Click here to get full coverage on Xencor (XNCR) Could Be 6% Below Fair Value On Its Antibody Pipeline Narrative - simplywall.st

Xencor (XNCR) Could Be 6% Below Fair Value On Its Antibody Pipeline Narrative  simplywall.st

Xencor (XNCR) Could Be 6% Below Fair Value On Its Antibody Pipeline Narrative - simplywall.st

Click here to get full coverage on Xencor (XNCR) Reports Q1 Loss, Lags Revenue Estimates - Yahoo Finance

Xencor (XNCR) Reports Q1 Loss, Lags Revenue Estimates  Yahoo Finance

Xencor (XNCR) Reports Q1 Loss, Lags Revenue Estimates - Yahoo Finance

Click here to get full coverage on Xencor, Inc. (NASDAQ:XNCR) Given Consensus Recommendation of "Hold" by Brokerages - MarketBeat

Xencor, Inc. (NASDAQ:XNCR) Given Consensus Recommendation of "Hold" by Brokerages  MarketBeat

Xencor, Inc. (NASDAQ:XNCR) Given Consensus Recommendation of "Hold" by Brokerages - MarketBeat

Click here to get full coverage on The Manufacturers Life Insurance Company Buys Shares of 49,696 Xencor, Inc. $XNCR - MarketBeat

The Manufacturers Life Insurance Company Buys Shares of 49,696 Xencor, Inc. $XNCR  MarketBeat

The Manufacturers Life Insurance Company Buys Shares of 49,696 Xencor, Inc. $XNCR - MarketBeat

Click here to get full coverage on Hsbc Holdings PLC Buys Shares of 125,482 Xencor, Inc. $XNCR - MarketBeat

Hsbc Holdings PLC Buys Shares of 125,482 Xencor, Inc. $XNCR  MarketBeat

Hsbc Holdings PLC Buys Shares of 125,482 Xencor, Inc. $XNCR - MarketBeat

Click here to get full coverage on Xencor (NASDAQ:XNCR) Stock Price Down 9% - What's Next? - MarketBeat

Xencor (NASDAQ:XNCR) Stock Price Down 9% - What's Next?  MarketBeat

Xencor (NASDAQ:XNCR) Stock Price Down 9% - What's Next? - MarketBeat

Click here to get full coverage on Legal & General Group Plc Acquires Shares of 1,091,177 Xencor, Inc. $XNCR - MarketBeat

Legal & General Group Plc Acquires Shares of 1,091,177 Xencor, Inc. $XNCR  MarketBeat

Legal & General Group Plc Acquires Shares of 1,091,177 Xencor, Inc. $XNCR - MarketBeat

Click here to get full coverage on JPMorgan Chase & Co. Forecasts Strong Price Appreciation for Xencor (NASDAQ:XNCR) Stock - MarketBeat

JPMorgan Chase & Co. Forecasts Strong Price Appreciation for Xencor (NASDAQ:XNCR) Stock  MarketBeat

JPMorgan Chase & Co. Forecasts Strong Price Appreciation for Xencor (NASDAQ:XNCR) Stock - MarketBeat

Click here to get full coverage on Xencor (NASDAQ:XNCR) Sees Large Volume Increase - Here's What Happened - MarketBeat

Xencor (NASDAQ:XNCR) Sees Large Volume Increase - Here's What Happened  MarketBeat

Xencor (NASDAQ:XNCR) Sees Large Volume Increase - Here's What Happened - MarketBeat

Click here to get full coverage on Deutsche Bank AG Acquires New Shares in Xencor, Inc. $XNCR - MarketBeat

Deutsche Bank AG Acquires New Shares in Xencor, Inc. $XNCR  MarketBeat

Deutsche Bank AG Acquires New Shares in Xencor, Inc. $XNCR - MarketBeat

Click here to get full coverage on XENCOR ($XNCR) Releases Q2 2026 Earnings - Quiver Quantitative

XENCOR ($XNCR) Releases Q2 2026 Earnings  Quiver Quantitative

XENCOR ($XNCR) Releases Q2 2026 Earnings - Quiver Quantitative

Click here to get full coverage on Xencor advances 17% after revealing ESMO 2026 oral presentation slot (XNCR:NASDAQ) - Seeking Alpha

Xencor advances 17% after revealing ESMO 2026 oral presentation slot (XNCR:NASDAQ)  Seeking Alpha

Xencor advances 17% after revealing ESMO 2026 oral presentation slot (XNCR:NASDAQ) - Seeking Alpha

Click here to get full coverage on Bank of America Corp DE Sells 263,315 Shares of Xencor, Inc. $XNCR - MarketBeat

Bank of America Corp DE Sells 263,315 Shares of Xencor, Inc. $XNCR  MarketBeat

Bank of America Corp DE Sells 263,315 Shares of Xencor, Inc. $XNCR - MarketBeat

Click here to get full coverage on Xencor: Bullish On Their Increasingly In-House Pipeline (NASDAQ:XNCR) - Seeking Alpha

Xencor: Bullish On Their Increasingly In-House Pipeline (NASDAQ:XNCR)  Seeking Alpha

Xencor: Bullish On Their Increasingly In-House Pipeline (NASDAQ:XNCR) - Seeking Alpha

Click here to get full coverage on Analysts Are Upgrading Xencor, Inc. (NASDAQ:XNCR) After Its Latest Results - simplywall.st

Analysts Are Upgrading Xencor, Inc. (NASDAQ:XNCR) After Its Latest Results  simplywall.st

Analysts Are Upgrading Xencor, Inc. (NASDAQ:XNCR) After Its Latest Results - simplywall.st

Click here to get full coverage on XNCR Maintained by JP Morgan -- Price Target Raised to $21.00 - GuruFocus

XNCR Maintained by JP Morgan -- Price Target Raised to $21.00  GuruFocus

XNCR Maintained by JP Morgan -- Price Target Raised to $21.00 - GuruFocus

Click here to get full coverage on Xencor Number of Employees 2026 | Employee Count & Headcount Data - Revelio Labs

Xencor Number of Employees 2026 | Employee Count & Headcount Data  Revelio Labs

Xencor Number of Employees 2026 | Employee Count & Headcount Data - Revelio Labs

Click here to get full coverage on Seven Fleet Capital Management LP Has $5.93 Million Stake in Xencor, Inc. $XNCR - MarketBeat

Seven Fleet Capital Management LP Has $5.93 Million Stake in Xencor, Inc. $XNCR  MarketBeat

Seven Fleet Capital Management LP Has $5.93 Million Stake in Xencor, Inc. $XNCR - MarketBeat

Click here to get full coverage on Bank of New York Mellon Corp Makes New Investment in Xencor, Inc. $XNCR - MarketBeat

Bank of New York Mellon Corp Makes New Investment in Xencor, Inc. $XNCR  MarketBeat

Bank of New York Mellon Corp Makes New Investment in Xencor, Inc. $XNCR - MarketBeat

Click here to get full coverage on Xencor: Strong Buy, XmAb819 Presentation, And End Of 2026 XmAb942 Interim Data - Seeking Alpha

Xencor: Strong Buy, XmAb819 Presentation, And End Of 2026 XmAb942 Interim Data  Seeking Alpha

Xencor: Strong Buy, XmAb819 Presentation, And End Of 2026 XmAb942 Interim Data - Seeking Alpha

Click here to get full coverage on Xencor to Present at the 2026 Cantor Global Healthcare Conference - Business Wire

Xencor to Present at the 2026 Cantor Global Healthcare Conference  Business Wire

Xencor to Present at the 2026 Cantor Global Healthcare Conference - Business Wire

Click here to get full coverage on (XNCR) Risk Channels and Responsive Allocation - news.stocktradersdaily.com

(XNCR) Risk Channels and Responsive Allocation  news.stocktradersdaily.com

(XNCR) Risk Channels and Responsive Allocation - news.stocktradersdaily.com

Click here to get full coverage on Do Xencor’s (XNCR) Mixed 2026 Loss Trends Hint at Shifting Cost Discipline? - simplywall.st

Do Xencor’s (XNCR) Mixed 2026 Loss Trends Hint at Shifting Cost Discipline?  simplywall.st

Do Xencor’s (XNCR) Mixed 2026 Loss Trends Hint at Shifting Cost Discipline? - simplywall.st

Click here to get full coverage on $XNCR stock is up 15% today. Here's what we see in our data. - Quiver Quantitative

$XNCR stock is up 15% today. Here's what we see in our data.  Quiver Quantitative

$XNCR stock is up 15% today. Here's what we see in our data. - Quiver Quantitative

Click here to get full coverage on Xencor, Inc. (XNCR) Discusses Phase I Results for XmAb942 and Preclinical Data for XmAb412 - Slideshow - Seeking Alpha

Xencor, Inc. (XNCR) Discusses Phase I Results for XmAb942 and Preclinical Data for XmAb412 - Slideshow  Seeking Alpha

Xencor, Inc. (XNCR) Discusses Phase I Results for XmAb942 and Preclinical Data for XmAb412 - Slideshow - Seeking Alpha

Click here to get full coverage on Xencor to Receive $105 Million From Alexion to Resolve Ultomiris® U.S. Royalty Matter - Business Wire

Xencor to Receive $105 Million From Alexion to Resolve Ultomiris® U.S. Royalty Matter  Business Wire

Xencor to Receive $105 Million From Alexion to Resolve Ultomiris® U.S. Royalty Matter - Business Wire

Click here to get full coverage on Xencor rises as AstraZeneca royalty row ends (XNCR:NASDAQ) - Seeking Alpha

Xencor rises as AstraZeneca royalty row ends (XNCR:NASDAQ)  Seeking Alpha

Xencor rises as AstraZeneca royalty row ends (XNCR:NASDAQ) - Seeking Alpha

Click here to get full coverage on Barclays Reaffirms Their Buy Rating on Xencor (XNCR) - The Globe and Mail

Barclays Reaffirms Their Buy Rating on Xencor (XNCR)  The Globe and Mail

Barclays Reaffirms Their Buy Rating on Xencor (XNCR) - The Globe and Mail

Click here to get full coverage on Xencor (XNCR) Reports Q3 Loss, Misses Revenue Estimates - Yahoo Finance

Xencor (XNCR) Reports Q3 Loss, Misses Revenue Estimates  Yahoo Finance

Xencor (XNCR) Reports Q3 Loss, Misses Revenue Estimates - Yahoo Finance

Click here to get full coverage on Industry Analysts Just Made A Huge Upgrade To Their Xencor, Inc. (NASDAQ:XNCR) Revenue Forecasts - webull.com

Industry Analysts Just Made A Huge Upgrade To Their Xencor, Inc. (NASDAQ:XNCR) Revenue Forecasts  webull.com

Industry Analysts Just Made A Huge Upgrade To Their Xencor, Inc. (NASDAQ:XNCR) Revenue Forecasts - webull.com

Click here to get full coverage on Ellen Feigal at Xencor (XNCR) receives RSUs and options equity awards - Stock Titan

Ellen Feigal at Xencor (XNCR) receives RSUs and options equity awards  Stock Titan

Ellen Feigal at Xencor (XNCR) receives RSUs and options equity awards - Stock Titan

Click here to get full coverage on Is Xencor (XNCR) Now Fairly Priced After Prolonged Share Price Declines - simplywall.st

Is Xencor (XNCR) Now Fairly Priced After Prolonged Share Price Declines  simplywall.st

Is Xencor (XNCR) Now Fairly Priced After Prolonged Share Price Declines - simplywall.st

Click here to get full coverage on Vanguard Capital Management (XNCR) discloses 3.8M-share, 5.13% stake in Xencor - Stock Titan

Vanguard Capital Management (XNCR) discloses 3.8M-share, 5.13% stake in Xencor  Stock Titan

Vanguard Capital Management (XNCR) discloses 3.8M-share, 5.13% stake in Xencor - Stock Titan

Click here to get full coverage on Xencor to Host Webcast to Discuss XmAb942 and XmAb412 Data Presentations at DDW - Business Wire

Xencor to Host Webcast to Discuss XmAb942 and XmAb412 Data Presentations at DDW  Business Wire

Xencor to Host Webcast to Discuss XmAb942 and XmAb412 Data Presentations at DDW - Business Wire

Click here to get full coverage on New Analyst Forecast: $XNCR Given $18.0 Price Target - Quiver Quantitative

New Analyst Forecast: $XNCR Given $18.0 Price Target  Quiver Quantitative

New Analyst Forecast: $XNCR Given $18.0 Price Target - Quiver Quantitative

Click here to get full coverage on Industry Analysts Just Made A Huge Upgrade To Their Xencor, Inc. (NASDAQ:XNCR) Revenue Forecasts - Sahm

Industry Analysts Just Made A Huge Upgrade To Their Xencor, Inc. (NASDAQ:XNCR) Revenue Forecasts  Sahm

Industry Analysts Just Made A Huge Upgrade To Their Xencor, Inc. (NASDAQ:XNCR) Revenue Forecasts - Sahm

Click here to get full coverage on Xencor Reports First Quarter 2026 Financial Results - Business Wire

Xencor Reports First Quarter 2026 Financial Results  Business Wire

Xencor Reports First Quarter 2026 Financial Results - Business Wire

Click here to get full coverage on Xencor Announces Change to Ultomiris® Royalty Revenue Forecast - Business Wire

Xencor Announces Change to Ultomiris® Royalty Revenue Forecast  Business Wire

Xencor Announces Change to Ultomiris® Royalty Revenue Forecast - Business Wire

Click here to get full coverage on Biotech Stocks At 52-Week Highs- CORT +30%, NEOG +22% & BAX +7% With Quarterly Results, TRAX, XNCR - RTTNews

Biotech Stocks At 52-Week Highs- CORT +30%, NEOG +22% & BAX +7% With Quarterly Results, TRAX, XNCR  RTTNews

Biotech Stocks At 52-Week Highs- CORT +30%, NEOG +22% & BAX +7% With Quarterly Results, TRAX, XNCR - RTTNews

Click here to get full coverage on Xencor to Participate at Upcoming Investor Conferences - Business Wire

Xencor to Participate at Upcoming Investor Conferences  Business Wire

Xencor to Participate at Upcoming Investor Conferences - Business Wire

Click here to get full coverage on Xencor stock hits 52-week high at 18.83 USD - Investing.com

Xencor stock hits 52-week high at 18.83 USD  Investing.com

Xencor stock hits 52-week high at 18.83 USD - Investing.com

Click here to get full coverage on symbol__ Stock Quote Price and Forecast - CNN

symbol__ Stock Quote Price and Forecast  CNN

symbol__ Stock Quote Price and Forecast - CNN

Click here to get full coverage on XNCR stock holds steady as Xencor eyes next trial milestones - ad-hoc-news.de

XNCR stock holds steady as Xencor eyes next trial milestones  ad-hoc-news.de

XNCR stock holds steady as Xencor eyes next trial milestones - ad-hoc-news.de

Click here to get full coverage on Core Biotech Trades For Friday (NASDAQ:RCKT) - Seeking Alpha

Core Biotech Trades For Friday (NASDAQ:RCKT)  Seeking Alpha

Core Biotech Trades For Friday (NASDAQ:RCKT) - Seeking Alpha

Click here to get full coverage on Xencor (XNCR) Session: Rises 2.96% to $27.80 in the Latest Reading; Price Setup: the Price Remains Bounded by the Supplied Support and Resistance on the Day - Channel Projection - dars.gov.et

Xencor (XNCR) Session: Rises 2.96% to $27.80 in the Latest Reading; Price Setup: the Price Remains Bounded by the Supplied Support and Resistance on the Day - Channel Projection  dars.gov.et

Xencor (XNCR) Session: Rises 2.96% to $27.80 in the Latest Reading; Price Setup: the Price Remains Bounded by the Supplied Support and Resistance on the Day - Channel Projection - dars.gov.et

Click here to get full coverage on XNCR Q1 2026 Earnings: EPS Misses Estimates by Wide Margin, Stock Declines - Management Tone Analysis - Vinanet

XNCR Q1 2026 Earnings: EPS Misses Estimates by Wide Margin, Stock Declines - Management Tone Analysis  Vinanet

XNCR Q1 2026 Earnings: EPS Misses Estimates by Wide Margin, Stock Declines - Management Tone Analysis - Vinanet

Click here to get full coverage on Xencor settles Ultomiris royalty dispute for $105 million - Investing.com

Xencor settles Ultomiris royalty dispute for $105 million  Investing.com

Xencor settles Ultomiris royalty dispute for $105 million - Investing.com

Click here to get full coverage on Xencor (XNCR) Session: Rises 2.96% to $27.80 in the Latest Reading; Price Setup: the Price Remains Bounded by the Supplied Support and Resistance on the Day - Technical Analysis Picks - dars.gov.et

Xencor (XNCR) Session: Rises 2.96% to $27.80 in the Latest Reading; Price Setup: the Price Remains Bounded by the Supplied Support and Resistance on the Day - Technical Analysis Picks  dars.gov.et

Xencor (XNCR) Session: Rises 2.96% to $27.80 in the Latest Reading; Price Setup: the Price Remains Bounded by the Supplied Support and Resistance on the Day - Technical Analysis Picks - dars.gov.et

Click here to get full coverage on Xencor Highlights Corporate Priorities and 2026 Pipeline Milestones - Business Wire

Xencor Highlights Corporate Priorities and 2026 Pipeline Milestones  Business Wire

Xencor Highlights Corporate Priorities and 2026 Pipeline Milestones - Business Wire

Click here to get full coverage on Xencor, Inc. (XNCR) Stock Analysis: Potential 103.89% Upside Amidst Strong Revenue Growth - DirectorsTalk Interviews

Xencor, Inc. (XNCR) Stock Analysis: Potential 103.89% Upside Amidst Strong Revenue Growth  DirectorsTalk Interviews

Xencor, Inc. (XNCR) Stock Analysis: Potential 103.89% Upside Amidst Strong Revenue Growth - DirectorsTalk Interviews

Click here to get full coverage on Xencor (XNCR) Stock Forecast and Price Target 2026 - MarketBeat

Xencor (XNCR) Stock Forecast and Price Target 2026  MarketBeat

Xencor (XNCR) Stock Forecast and Price Target 2026 - MarketBeat

Click here to get full coverage on Caris Life Sciences and Xencor Expand Target Discovery Collaboration for Novel XmAb® Antibody Drug Candidates - PR Newswire

Caris Life Sciences and Xencor Expand Target Discovery Collaboration for Novel XmAb® Antibody Drug Candidates  PR Newswire

Caris Life Sciences and Xencor Expand Target Discovery Collaboration for Novel XmAb® Antibody Drug Candidates - PR Newswire

Click here to get full coverage on XNCR Q1 2026 Earnings: Deep Loss Miss as Pipeline Biotech Faces Market Skepticism - Short-Term Outlook - dars.gov.et

XNCR Q1 2026 Earnings: Deep Loss Miss as Pipeline Biotech Faces Market Skepticism - Short-Term Outlook  dars.gov.et

XNCR Q1 2026 Earnings: Deep Loss Miss as Pipeline Biotech Faces Market Skepticism - Short-Term Outlook - dars.gov.et

Click here to get full coverage on XNCR Q2 2026 Earnings: Narrower-Than-Expected Loss Drives 4.89% Share Uptick - Guidance Accuracy Score - dars.gov.et

XNCR Q2 2026 Earnings: Narrower-Than-Expected Loss Drives 4.89% Share Uptick - Guidance Accuracy Score  dars.gov.et

XNCR Q2 2026 Earnings: Narrower-Than-Expected Loss Drives 4.89% Share Uptick - Guidance Accuracy Score - dars.gov.et

Click here to get full coverage on XNCR Q1 2026 Earnings: Wider-than-Expected Loss and No Revenue Highlight Pipeline Challenges - dars.gov.et

XNCR Q1 2026 Earnings: Wider-than-Expected Loss and No Revenue Highlight Pipeline Challenges  dars.gov.et

XNCR Q1 2026 Earnings: Wider-than-Expected Loss and No Revenue Highlight Pipeline Challenges - dars.gov.et

Click here to get full coverage on XNCR Q1 2026 Earnings: Loss Widens Beyond Estimates, Stock Surges on Pipeline Optimism - Free Cash Flow Trends - dars.gov.et

XNCR Q1 2026 Earnings: Loss Widens Beyond Estimates, Stock Surges on Pipeline Optimism - Free Cash Flow Trends  dars.gov.et

XNCR

Price Chart

Key Statistics

Technicals

About XNCR

Latest News

Xencor (XNCR) Heads To Cantor Conference With Fair Value Still In Focus - simplywall.st

Avoiding Lag: Real-Time Signals in (XNCR) Movement - news.stocktradersdaily.com

$XNCR stock is down 11% today. Here's what we see in our data. - Quiver Quantitative

Advanced Charts

Top Gainers

Top Losers